{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:23Z","timestamp":1760188883349},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11926-996-0008-4","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:18:19Z","timestamp":1180783099000},"page":"387-390","source":"Crossref","is-referenced-by-count":9,"title":["Juvenile systemic scleroderma"],"prefix":"10.1007","volume":"3","author":[{"given":"Alberto","family":"Martini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","volume-title":"Textbook of Pediatric Rheumatology","author":"JT Cassidy","year":"1995","unstructured":"Cassidy JT, Petty RE: Textbook of Pediatric Rheumatology. Philadelphia: WB Saunders; 1995."},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1961.01580150005001","volume":"84","author":"DL Tuffanelli","year":"1961","unstructured":"Tuffanelli DL, Winkelmann RK: Systemic scleroderma. Arch Dermatol 1961, 84:359\u2013371.","journal-title":"Arch Dermatol"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0031-3955(16)40058-1","volume":"42","author":"Y Uziel","year":"1995","unstructured":"Uziel Y, Miller ML, Laxer RM: Scleroderma in children. Pediatr Clin North Am 1995, 42:1171\u20131203.","journal-title":"Pediatr Clin North Am"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4615-4857-7_6","volume":"455","author":"CM Black","year":"1999","unstructured":"Black CM: Scleroderma in children. Adv Exp Med Biol 1999, 455:35\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-2133.1996.116851.x","volume":"134","author":"SA Bell","year":"1996","unstructured":"Bell SA, Faust H, Mittermuller J, et al.: Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 1996, 134:848\u2013854.","journal-title":"Br J Dermatol"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood.V88.11.4390.bloodjournal88114390","volume":"88","author":"YMD Lo","year":"1996","unstructured":"Lo YMD, Lo ESF, Watson N, et al.: Two-way cell traffic between mother and fetus: biological and clinical implications. Blood 1996, 88:4390\u20134395.","journal-title":"Blood"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1073\/pnas.93.2.705","volume":"93","author":"DW Bianchi","year":"1996","unstructured":"Bianchi DW, Zickwolf GK, Weil GJ, et al.: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996, 93:705\u2013708.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(97)08357-8","volume":"351","author":"JL Nelson","year":"1998","unstructured":"Nelson JL, Furst DE, Maloney S, et al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559\u2013562.","journal-title":"Lancet"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199804233381704","volume":"338","author":"CM Artlett","year":"1998","unstructured":"Artlett CM, Smith BJ, Jimenez S: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998, 338:1186\u20131191.","journal-title":"N Engl J Med"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s002510050321","volume":"47","author":"CM Artlett","year":"1997","unstructured":"Artlett CM, Welsh KI, Black CM, et al.: Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics 1997, 47:17\u201322.","journal-title":"Immunogenetics"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.V93.6.2033.406k18_2033_2037","volume":"93","author":"PC Evans","year":"1999","unstructured":"Evans PC, Lambert N, Maloney S, et al.: Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033\u20132037. A study showing persistent fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with systemic scleroderma.","journal-title":"Blood"},{"key":"8_CR12","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.164.11.5545","volume":"164","author":"NC Lambert","year":"2000","unstructured":"Lambert NC, Evans PC, Hashizumi TL, et al.: Persistent fetal microchimerism in T lymphocytes is associated with HLADQA1* 0501: implications in autoimmunity. J Immunol 2000, 164:5545\u20135548. This study suggests an additional route by which HLA genes may contribute to susceptibility to autoimmune diseases.","journal-title":"J Immunol"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJM198209093071106","volume":"307","author":"MS Pollack","year":"1982","unstructured":"Pollack MS, Kirpatrick D, Kapoor D, et al.: Identification by HLA typing of intrauterine derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982, 307:662\u2013666.","journal-title":"N Engl J Med"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1172\/JCI6611","volume":"104","author":"S Maloney","year":"1999","unstructured":"Maloney S, Smith A, Furst D, et al.: Microchimerism of maternal origin persists into adult life. J Clin Invest 1999, 104:41\u201347. This study indicates that maternal cells can persist in immunocompetent offspring well into adult life.","journal-title":"J Clin Invest"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/1529-0131(200005)43:5<1062::AID-ANR16>3.0.CO;2-P","volume":"43","author":"CM Artlett","year":"2000","unstructured":"Artlett CM, Cox LA, Jimenez SA: Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 2000, 43:1062\u20131067. The study identifies the presence of microchimerism in male and female patients with systemic scleroderma and provides support for the hypothesis that persistent microchimerism plays a role in the pathogenesis of the disease.","journal-title":"Arthritis Rheum"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.V93.9.3127","volume":"93","author":"T-H Lee","year":"1999","unstructured":"Lee T-H, Paglieroni T, Ohto H, et al.: Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999, 93:3127\u2013139.","journal-title":"Blood"},{"key":"8_CR17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/rheumatology\/39.5.556","volume":"39","author":"I Foeldvari","year":"2000","unstructured":"Foeldvari I, Zhavania M, Birdi N, et al.: Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology 2000, 39:556\u2013559. Results from this mail survey suggest a better outcome for juvenile systemic scleroderma.","journal-title":"Rheumatology"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2214\/ajr.170.3.9490955","volume":"170","author":"JM Seely","year":"1998","unstructured":"Seely JM, Jones LT, Wallave C, et al.: Systemic sclerosis: using high-resolution CT to detect lung disease in children. Am J Roentgenol 1998, 170:691\u2013697.","journal-title":"Am J Roentgenol"},{"key":"8_CR19","first-page":"2692","volume":"27","author":"P Weber","year":"2000","unstructured":"Weber P, Ganser G, Frosch M, et al.: Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol 2000, 27:2692\u20132695.","journal-title":"J Rheumatol"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","volume":"42","author":"PJ Clements","year":"1999","unstructured":"Clements PJ, Furst DE, Wong WK, et al.: High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999, 42:1194\u20131203. A controlled trial questioning the efficacy of D-penicillamine in the treatment of systemic sclerosis.","journal-title":"Arthritis Rheum"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","volume":"42","author":"CM Black","year":"1999","unstructured":"Black CM, Silman AJ, Herrick AI, et al.: Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, doubleblind, placebo-controlled trial. Arthritis Rheum 1999, 42:299\u2013305. A controlled trial showing that interferon-alpha is of no value in the treatment of systemic scleroderma.","journal-title":"Arthritis Rheum"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0190-9622(99)70246-X","volume":"41","author":"DN Enomoto","year":"1999","unstructured":"Enomoto DN, Mekkes JR, Bossuyt PM, et al.: Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 1999, 41:915\u2013922.","journal-title":"J Am Acad Dermatol"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041552-199507000-00005","volume":"4","author":"K Casteels","year":"1995","unstructured":"Casteels K, Bouillon R, Waer M, et al.: Immunomodulatory effects of 1,25-dihydroxyvitamin D3. Curr Opin Nephrol Hypertens 1995, 4:313\u2013318.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","volume":"43","author":"MM Hulshof","year":"2000","unstructured":"Hulshof MM, Bavinck JN, Bergman W, et al.: Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000, 43:1017\u20131023.","journal-title":"J Am Acad Dermatol"},{"key":"8_CR25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1702626","volume":"26","author":"PV Browne","year":"2000","unstructured":"Browne PV, Weisdorf DJ, DeFor T, et al.: Response to thalidomide therapy in refractory chronic graft-versus-host disease. Bone Marrow Transplant 2000, 26:865\u2013869.","journal-title":"Bone Marrow Transplant"},{"key":"8_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/clim.2000.4920","volume":"97","author":"SJ Oliver","year":"2000","unstructured":"Oliver SJ, Moreira A, Kaplan G: Immune stimulation in scleroderma patients treated with thalidomide. Clin Immunol 2000, 97:109\u2013120.","journal-title":"Clin Immunol"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/1529-0131(200005)43:5<1054::AID-ANR14>3.0.CO;2-W","volume":"43","author":"KM McKown","year":"2000","unstructured":"McKown KM, Carbone LD, Bustillo J, et al.: Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis Rheum 2000, 43:1054\u20131061. Describes the use of oral type I collagen in patients with systemic scleroderma to induce tolerance to collagen type I. Induction of tolerance to collagen type I is worth investigating as a possible new treatment of systemic sclerosis.","journal-title":"Arthritis Rheum"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","volume":"132","author":"DB Badesch","year":"2000","unstructured":"Badesch DB, Tapson VT, McGoon MD, et al.: Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial. Ann Intern Med 2000, 132:425\u2013434. An important study showing the efficacy of intravenous epoprostenol in the treatment of pulmonary hypertension in systemic scleroderma.","journal-title":"Ann Intern Med"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X","volume":"42","author":"ES Klings","year":"1999","unstructured":"Klings ES, Hill NS, Ieong MH, et al.: Systemic sclerosisassociated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin). Arthritis Rheum 1999, 42:2638\u20132645. Another study supporting the efficacy of epoprostenol in the treatment of pulmonary hypertension in systemic scleroderma.","journal-title":"Arthritis Rheum"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","volume":"132","author":"Jr Seibold","year":"2000","unstructured":"Seibold Jr, Korn JH, Simms E, et al.: Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000, 132:871\u2013819. Another important study in which administration of recombinant human relaxin, a pregnancy-related hormone that has tissue remodeling and antifibrotic effect, was associated with reduced skin thickening, improved mobility, and improved function.","journal-title":"Ann Intern Med"},{"key":"8_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.med.51.1.115","volume":"51","author":"AM Marmont","year":"2000","unstructured":"Marmont AM: New horizons in the treatment of autoimmune diseases: immunoablation and stem cell transplantation. Ann Rev Med 2000, 51:115\u2013134. An excellent review on stem cell transplantation in autoimmune diseases including systemic scleroderma.","journal-title":"Ann Rev Med"},{"key":"8_CR32","first-page":"839","volume":"84","author":"F Locatelli","year":"1999","unstructured":"Locatelli F, Perotti C, Torretta L, et al.: Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis. Haematologica 1999, 84:839\u2013843.","journal-title":"Haematologica"},{"key":"8_CR33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/1529-0131(199904)42:4<807::AID-ANR26>3.0.CO;2-T","volume":"42","author":"A Martini","year":"1999","unstructured":"Martini A, Maccario R, Ravelli A, et al.: Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999, 42:807\u2013811. The first autologous hemopoietic stem cell transplant electively performed in childhood for the treatment of an autoimmune disease.","journal-title":"Arthritis Rheum"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","volume":"132","author":"B White","year":"2000","unstructured":"White B, Moore WC, Wigley FM, et al.: Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000, 132:947\u2013954. A retrospective study showing that lung function outcomes and survival are improved in patients with alveolitis who received cyclophosphamide.","journal-title":"Ann Intern Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-996-0008-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-996-0008-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:13:59Z","timestamp":1587575639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-996-0008-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11926-996-0008-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}